GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $60,000 | -46.4% | 2,053 | -20.0% | 0.03% | -45.2% |
| Q2 2022 | $112,000 | 0.0% | 2,567 | 0.0% | 0.06% | +26.5% |
| Q1 2022 | $112,000 | -0.9% | 2,567 | 0.0% | 0.05% | +6.5% |
| Q4 2021 | $113,000 | +15.3% | 2,567 | 0.0% | 0.05% | +4.5% |
| Q3 2021 | $98,000 | -10.9% | 2,567 | -7.2% | 0.04% | -10.2% |
| Q2 2021 | $110,000 | -65.9% | 2,767 | -69.4% | 0.05% | -69.2% |
| Q1 2021 | $323,000 | -20.6% | 9,050 | -18.1% | 0.16% | -29.0% |
| Q4 2020 | $407,000 | -16.4% | 11,050 | -14.7% | 0.22% | -30.7% |
| Q3 2020 | $487,000 | -11.9% | 12,950 | -4.4% | 0.32% | -14.3% |
| Q2 2020 | $553,000 | +6.8% | 13,550 | -0.8% | 0.38% | -11.1% |
| Q1 2020 | $518,000 | -21.0% | 13,665 | -2.1% | 0.42% | +5.0% |
| Q4 2019 | $656,000 | -2.5% | 13,965 | -11.4% | 0.40% | -7.1% |
| Q3 2019 | $673,000 | -16.4% | 15,765 | -21.7% | 0.44% | -18.7% |
| Q2 2019 | $805,000 | -5.2% | 20,125 | -1.0% | 0.54% | -5.0% |
| Q1 2019 | $849,000 | +1.4% | 20,325 | -7.2% | 0.56% | -4.4% |
| Q4 2018 | $837,000 | -11.1% | 21,900 | -6.6% | 0.59% | +5.4% |
| Q3 2018 | $942,000 | -4.1% | 23,450 | -3.7% | 0.56% | -7.1% |
| Q2 2018 | $982,000 | -6.1% | 24,350 | -9.1% | 0.60% | -6.7% |
| Q1 2018 | $1,046,000 | -38.7% | 26,775 | -44.3% | 0.64% | -36.2% |
| Q4 2017 | $1,705,000 | -8.8% | 48,075 | +4.5% | 1.01% | -14.7% |
| Q3 2017 | $1,869,000 | -7.2% | 46,025 | -1.4% | 1.18% | -11.1% |
| Q2 2017 | $2,013,000 | +6.2% | 46,675 | +3.8% | 1.33% | +5.5% |
| Q1 2017 | $1,896,000 | +15.4% | 44,975 | +5.4% | 1.26% | +11.2% |
| Q4 2016 | $1,643,000 | +238.8% | 42,675 | +279.3% | 1.14% | +200.8% |
| Q3 2016 | $485,000 | +18.3% | 11,250 | +19.0% | 0.38% | +15.6% |
| Q2 2016 | $410,000 | +12.9% | 9,450 | +5.6% | 0.33% | +12.4% |
| Q1 2016 | $363,000 | +13.8% | 8,950 | +13.3% | 0.29% | +21.8% |
| Q4 2015 | $319,000 | +4.9% | 7,900 | 0.0% | 0.24% | -0.4% |
| Q3 2015 | $304,000 | +6.7% | 7,900 | +15.3% | 0.24% | +12.7% |
| Q2 2015 | $285,000 | +11.3% | 6,850 | +23.4% | 0.21% | +12.1% |
| Q1 2015 | $256,000 | – | 5,550 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |